The reduced protein levels of KAP1 following SMURF2 depletion were also observed in other cancer cell models, including cervix carcinoma HeLa cells, prostate carcinoma DU-145 cells, and breast adenocarcinoma MDA-MB-468 cells. This evidence concerns the gene SMURF2 and prostate carcinoma.